Marco Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Buy
1,979
+32
+2% +$32.4K 0.14% 101
2025
Q4
$2.09M Sell
1,947
-45
-2% -$43K 0.16% 91
2025
Q3
$1.52M Sell
1,992
-18
-0.9% -$13.4K 0.12% 101
2025
Q2
$1.57M Sell
2,010
-37
-2% -$28.8K 0.13% 98
2025
Q1
$1.69M Buy
2,047
+88
+4% +$73.2K 0.16% 93
2024
Q4
$1.51M Sell
1,959
-88
-4% -$72.9K 0.13% 98
2024
Q3
$1.81M Sell
2,047
-66
-3% -$59.3K 0.16% 91
2024
Q2
$1.91M Buy
2,113
+42
+2% +$33.6K 0.18% 86
2024
Q1
$1.61M Sell
2,071
-159
-7% -$113K 0.15% 97
2023
Q4
$1.3M Sell
2,230
-23
-1% -$13.4K 0.13% 105
2023
Q3
$1.21M Buy
2,253
+50
+2% +$25.8K 0.14% 104
2023
Q2
$1.03M Buy
2,203
+12
+0.5% +$5.03K 0.11% 112
2023
Q1
$752K Hold
2,191
0.08% 130
2022
Q4
$802K Sell
2,191
-350
-14% -$124K 0.09% 125
2022
Q3
$822K Buy
2,541
+300
+13% +$95K 0.1% 121
2022
Q2
$727K Buy
2,241
+100
+5% +$30K 0.08% 127
2022
Q1
$613K Sell
2,141
-51
-2% -$13.1K 0.06% 143
2021
Q4
$605K Buy
2,192
+92
+4% +$23.3K 0.06% 144
2021
Q3
$485K Hold
2,100
0.05% 150
2021
Q2
$482K Hold
2,100
0.06% 144
2021
Q1
$392K Hold
2,100
0.05% 145
2020
Q4
$355K Hold
2,100
0.05% 145
2020
Q3
$311K Hold
2,100
0.05% 142
2020
Q2
$345K Hold
2,100
0.06% 133
2020
Q1
$291K Hold
2,100
0.06% 136
2019
Q4
$276K Sell
2,100
-17
-0.8% -$1.97K 0.04% 153
2019
Q3
$237K Hold
2,117
0.04% 159
2019
Q2
$235K Sell
2,117
-18
-0.8% -$2.12K 0.04% 160
2019
Q1
$277K Hold
2,135
0.05% 156
2018
Q4
$247K Sell
2,135
-19
-0.9% -$2.12K 0.05% 155
2018
Q3
$231K Buy
+2,154
New +$215K 0.03% 169
2016
Q3
Sell
-2,805
Closed -$221K 184
2016
Q2
$221K Buy
+2,805
New +$211K 0.04% 170
2016
Q1
Sell
-2,555
Closed -$215K 189
2015
Q4
$215K Hold
2,555
0.04% 185
2015
Q3
$214K Hold
2,555
0.04% 175
2015
Q2
$213K Sell
2,555
-1,000
-28% -$76.2K 0.04% 187
2015
Q1
$258K Buy
+3,555
New +$253K 0.04% 168

Other funds holding LLY

Marco Investment Management's LLY Position: Q1 2026 in Review

Marco Investment Management increased its Eli Lilly (LLY) stake by 1.6% in Q1 2026, buying an estimated $32.4K and bringing the position to 1,979 shares worth $1.82M. The position accounts for 0.14% of the portfolio, ranked #101.

Marco Investment Management first reported a position in LLY in Q1 2015 and has held it in 36 quarters since. The position peaked at $2.09M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Marco Investment Management held 1,979 shares of Eli Lilly worth $1.82M as of Q1 2026.
  • Marco Investment Management bought 32 Eli Lilly shares in Q1 2026, an estimated $32.4K.
  • Eli Lilly made up 0.14% of Marco Investment Management's portfolio in Q1 2026, its #101 holding.
  • Marco Investment Management first reported a position in Eli Lilly in Q1 2015 and has held it in 36 quarters since.
  • Marco Investment Management's Eli Lilly position peaked at $2.09M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.